comparemela.com

Aiolos Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GSK s experimental drug shows promise in reducing severe asthma attacks

GSK s experimental drug met its primary goal of reducing asthma attacks in a late-stage trial, marking a bright spot for a treatment that the British drugmaker expects to make peak annual sales of 3.

United kingdomNivedita bhattacharjeeEva mathewsAiolos bioTony wood

GSK s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial -- 2nd Update

By Najat Kantouar and Helena Smolak GSK s experimental drug for asthma met its goals in the latest trial, moving a treatment with potential annual peak sales of more than 3 billion pounds .

United kingdomHelena smolakEmma walmsleyNajat kantouarAiolos bioChief executive emma walmsleyDow jones

Experimental Drug Significantly Reduces Asthma Attacks

Experimental Drug Significantly Reduces Asthma Attacks
newsmax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmax.com Daily Mail and Mail on Sunday newspapers.

United kingdomAiolos bioTony wood

Health: GSK s experimental drug shows promise in reducing severe asthma attacks

Health: GSK s experimental drug shows promise in reducing severe asthma attacks
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United kingdomAiolos bioTony wood

GSK s experimental drug reduces asthma attacks in late-stage trial

Tha pharma giant, which is building out its respiratory portfolio, shared results of a late-stage clinical trial for its long-acting asthma medication

City ofUnited kingdomUnited statesAiolos bioWall street journal

vimarsana © 2020. All Rights Reserved.